Cajeta, Arian .

HRN: 22-34-64  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/24/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/24/2022
12/31/2022
IV
1.2 G
Q6
Periapical Abscess On Molar Tooth (Lower Jaw) Right
Waiting Final Action 

Indication:  EmpiricEmpirical Escalation    Type of Infection:  Eye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: